Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AB1 | P08238 | 2/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | TACR3 | P29371 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21326025 | 1.00 | HSP90AB1 (0.68) | HSP90AB1CYP1A2CYP2D6CYP2C9TACR3 | |
| SCHEMBL29587104 | 0.92 | PDGFRB (0.58) | HSP90AB1 | |
| SCHEMBL21326011 | 0.92 | PDGFRB (0.58) | HSP90AB1 | |
| SCHEMBL21325971 | 0.91 | HSP90AB1 (0.56) | HSP90AB1 | |
| SCHEMBL29586847 | 0.91 | HSP90AB1 (0.56) | HSP90AB1 | |
| SCHEMBL21325974 | 0.89 | HSP90AB1 (0.68) | HSP90AB1TACR3 | |
| SCHEMBL22295251 | 0.89 | HSP90AB1 (0.54) | HSP90AB1 | |
| SCHEMBL29587216 | 0.89 | HSP90AB1 (0.68) | HSP90AB1TACR3 | |
| SCHEMBL21326038 | 0.89 | HSP90AB1 (0.54) | HSP90AB1 | |
| SCHEMBL21326010 | 0.89 | HSP90AB1 (0.54) | HSP90AB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110088103-B | Novel tetrahydropyridopyrimidine compounds for the treatment and prophylaxis of hepatitis b virus infection | 豪夫迈·罗氏有限公司 | 2022-04-12 | — | — | CN | claimed |
| CN-110088103-B | Novel tetrahydropyridopyrimidine compounds for the treatment and prophylaxis of hepatitis b virus infection | 豪夫迈·罗氏有限公司 | 2022-04-12 | — | — | CN | disclosed |